Why the UK is lagging behind other countries on measles vaccinations
Now, health officials in the UK have sounded the alarm over our waning vaccine coverage after a child with measles died in Liverpool.
On Monday, health secretary Wes Streeting said that the child's death shows the nation needs to 'redouble its efforts' to vaccinate more children and said improvements promised in the NHS's 10-year plan, such as giving parents access to digital health records, could help.
One expert told The Independent a multitude of issues have impacted the UK's measles vaccination rates, including declining public health budgets, lower access to GP services, and the increased circulation of misinformation on social media.
Data published by the World Health Organisation (WHO) and the charity UNICEF estimates the UK has just 89 per cent coverage of the first measles vaccine in 2024 and 85 per cent coverage of the second dose.
This is down from 93 per cent a decade earlier and well below WHO target of 95 per cent, which it said is needed to effectively eliminate the spread of the disease in the community.
And we're lagging well behind our G& counterparts, with vaccine rates in Germany the highest (96 per cent), Italy and France (95 per cent) and Japan (94 per cent)/.
The organisations warned that the global rates of childhood vaccinations are falling, with 30 million children unvaccinated.
Rates of the first MMR vaccine across the UK have been in decline since 2014. An analysis by the Nuffield Trust of 2023-24 data shows England lags behind Wales, Scotland and Northern Ireland on coverage of this vaccine.
Within England, London has the worst coverage by far, with just 81 per cent of children having received a first course by their second birthday. Data as of June 2025 shows that the capital accounted for 44 per cent of all measles cases.
Measles is a highly contagious, serious airborne disease caused by a virus that can lead to severe complications and death.
Dr Connor Bamford, Virologist, Queen's University Belfast, explained: 'Various conditions can make individuals more vulnerable to severe measles. This may include immunosuppressed individuals undergoing cancer treatment for example who, because of their condition, have lost immunity to the virus, even if they have been vaccinated."
He said: "We do see children and adults dying from measles in the UK and the last young person who died was reported in 2024. In 2023, we saw another child die of a disease called SSPE (subacute sclerosing panencephalitis), which is a fatal complication of measles that occurs years after an earlier infection. In 2023 two adults also died."
In the UK, immunisation against it is typically given as part of the MMR vaccine for measles, mumps and rubella.
According to the NHS, around 99 per cent of people who receive the MMR vaccine will be protected against measles and rubella. Meanwhile, around 88 per cent will be protected against mumps, and anyone who does get it after vaccination will experience milder symptoms.
According to the Nuffield Trust, uptake of the MMR vaccine decreased significantly following a now discredited article by Dr Andrew Wakefield in 1998, which linked MMR vaccination to autism. By 2003-04 uptake of the vaccine had dropped to 80 per cent.
However, coverage then improved and hit 93 per cent in 2013-14, before dropping again to 89 per cent in 2023-24.
A recent survey by the UK Health Security Agency (UKHSA) suggested that overall, parents in the UK have a high level of confidence that vaccines work for children, with 87 per cent of those surveyed having agreed with this.
However, vaccine coverage for MMR and other key childhood vaccines has declined in recent years, and now health officials are urging parents to get their children vaccinated.
Speaking with The Independent, Adam Finn, Professor of Paediatrics at the University of Bristol, and a member of the government's Joint Vaccinations and Immunisations Committee, explained there were several factors, including the fact that there has been a general decline in immunisation over the past 15 years, which had initially been ignored.
He said: 'The public health authority officials favour the idea that it's because there's been a waning of resource in the health service to deliver the vaccine programme, so as primary care in particular has become more stretched the capacity to chase people up and go after the people that are otherwise not getting their act together has disappeared and that's resulted in the vulnerable edge getting worse and worse.'
'The competing hypothesis, which is quite convenient for the politicians, is that it's mad internet misinformation, and in a sense, people are somehow to blame for believing it and that it's not really a governmental problem, it's myth and legend, as it were.'
'My view is that those two things are not mutually exclusive.'
He said while there are a group of parents and people who avoid vaccination, there are another group who don't do it because they're not aware, or it's not high up on their priority list.
The professor of paediatrics also suggested that vaccines, such as MMR, were a victim of their own success, with the public no longer having a living memory of the severe and life-threatening impacts of the disease.
In the 1960s, people would've queued around the block to get their children immunised because they were afraid of them dying of those diseases where whereas now they've never heard of them, he said.
One key solution is enabling healthcare workers, such as GPs or health visitors, to have conversations around vaccines with parents, says Professor Finn.
'The government has come in with a mission to solve the problem of the under-resourced health service and has emphasised the way it wants to do that is to stop people from getting ill rather than build more hospitals.
'And one of the most obvious and effective, proven and countable ways of doing that is to ensure vaccine programmes are delivered, and so I think it should be a fairly open and closed argument that this is where Wes Streeting needs to put his money.'
Where access to GPs and health visitors is an issue, experts have suggested expanding the list of places where parents can get vaccines, and information about them could help.
Malcolm Harrison, Chief Executive of the Company Chemists' Association (CCA), has suggested pharmacies could assist.
He said last year, a pilot in the North West of England allowed children aged 5 to 11 who had missed doses to get the MMR vaccine at their local pharmacy for the first time.
Experts have also suggested that schools could be an important place for children's vaccines to be accessed.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

an hour ago
More than 14M children globally have not received a dose of any vaccine: WHO
More than 14 million children around the world have not received a single dose of any vaccine, according to new data from the World Health Organization (WHO) and UNICEF. This is 4 million more children than the 2024 target set by the WHO and 1.4 million more children than in 2019, which is the baseline year for measuring progress. About 25% of the world's infants live in 26 countries that are affected by conflict, fragility or humanitarian crises, but they make up half of all unvaccinated children, according to the global health agency. Children are unvaccinated or under-vaccinated for many reasons including lack of access, disrupted supply, conflict and instability, or misinformation about vaccines. "Stalling of vaccine coverage, even the smallest drops in immunization coverage as measured at the country level, can have devastating consequences," Dr. Kate O'Brien, director of the WHO's Department of Immunization, Vaccines and Biologicals, said during a press briefing on Monday. "It opens the door to deadly disease outbreaks and puts even more pressure on health systems that are already stretched. Immunization Agenda 2030 targets are in reach to protect more children [with] life-saving vaccines." Immunization Agenda 2030 is in reference to a series of goals put forth by the World Health Assembly to address challenges in improving access. However, there were some bright spots in the report. In 2024, 89% of infants globally, equivalent to about 115 million, received at least one dose of the diphtheria, tetanus and pertussis (DTP)-containing vaccine, and 85%, roughly 109 million, completed all three doses. By comparison, in 2023, about 171,000 more children received at least one vaccine and one million more children received the three doses. Protection against measles also improved, with 84% of children receiving the first dose and 76% receiving the second dose. While these are slight increases from the previous year, it means 30 million children are unprotected, especially as the world faces an increasing number of outbreaks. "The good news is that we have managed to reach more children with life-saving vaccines. But millions of children remain without protection against preventable diseases, and that should worry us all," Catherine Russell, executive director of UNICEF, said in a statement. "We must act now with determination to overcome barriers like shrinking health budgets, fragile health systems along with misinformation and access constraints because of conflicts. No child should die from a disease we know how to prevent," Russell said. The release of the data came just a few weeks after Health and Human Secretary Robert F. Kennedy Jr. said the U.S. was pulling its funding from GAVI, an international organization that works to improve access to vaccines, claiming the organization "ignored the science." Kennedy claimed in a video posted online that the U.S. had provided $8 billion in funding to GAVI since 2001. Public health officials called on governments around the world to help fill the gaps in funding, although the U.S. withholding funds was not explicitly stated. "It is really, really important that maintaining these coverage trends, which are quite easily fragile unless efforts are sustained," Dr. Ephrem Lemango, associate director for health and global chief of immunization at UNICEF, said during Monday's press briefing. "It is important that we maintain our commitment to immunization, and we're calling on governments and partners and communities to do all that is necessary to maintain immunization coverage, including closing the funding gaps, serving communities in conflict and fragile settings, and addressing misinformation," Lemango said.


Black America Web
2 hours ago
- Black America Web
Tamar Braxton & Gilead Partner For PrEP Promo To Black Women
Getty Images for ESSENCE Tamar Braxton has always been one to use her voice for good — good music, that is! — and now she's getting even louder with a new partnership alongside Gilead Sciences that will aim to promote HIV prevention like PrEP specifically to Black women. The big news was revealed this past weekend during Essence Festival 2025, where Tamar sat on the 'Safe & Sexy' panel for those who were able to visit the Global Black Economic Forum stage. RELATED: FDA Approves First And Only Twice-Yearly PrEP Option 'I'm all about dating with confidence,' she shared with guests on her reasoning behind the Gilead union, going on further add, 'Black women have stopped talking about HIV, and it needs to be part of our conversation again.' This comes not too long after Tamar went viral earlier this year for revealing that she herself takes PrEP, at the time sharing the news in a video posted to social media (seen below) where she blamed the current dating pool and its lack of options for, in her words, 'not being for the outside.' For Gilead, the partnership comes with perfect timing following The World Health Organization officially recommending its twice-yearly PrEP injection, lenacapavir, in the global fight against HIV infection. More details below, via Reuters : 'The recommendation, issued at the International AIDS Conference in Kigali, Rwanda, comes nearly a month after the U.S. health regulator approved the drug, giving patients new hope of interrupting virus transmission. The twice-yearly injectable offers a long-acting alternative to daily oral pills and other shorter-acting options, reshaping the response to the disease especially among those who face challenges with daily adherence, stigma, or access to health care. 'While an HIV vaccine remains elusive, lenacapavir is the next best thing,' said Tedros Adhanom Ghebreyesus, WHO Director-General. The WHO's recommendations come at a critical moment as HIV prevention efforts stagnate with 1.3 million new HIV infections occurring in 2024 as funding challenges, stigma around the disease persist.' As we all should know by now, HIV has affected the Black community at a disproportionate rate compared to other race groups since the epidemic first began decades ago. As a result, we should be doing everything in our power to change those statistics and hopefully rid them altogether. Shoutout to Tamar for using her platform to spread some news that can save a life. You can visit HealthySexuals to get educated on PrEP medications and other honest conversations. SEE ALSO
Yahoo
3 hours ago
- Yahoo
OPINION - A once-a-day ‘life-changing' pill for cystic fibrosis patients ...Tech & Science Daily podcast
Listen here on your chosen podcast platform. A once-a-day pill health experts are calling 'life-changing' will be offered to hundreds of people living with cystic fibrosis. The drug, called Alyftrek, is a type of modular therapy which works to tackle the underlying cause of the rare condition. NHS England has announced that the treatment will be available for children and adults with rare forms of cystic fibrosis. A new £650 million Electric Car Grant announced by the government is set to reduce the cost of some new electric cars. We speak with Octopus Energy CEO Greg Jackson about the technology behind their new EV bundle, which includes free charging. Plus, Nvidia are getting the ball rolling again for sales of their famous chips in China. Also in this episode: -Blue Sharks have a unique structure on their skin which allows them to change colour -Elon Musk's Grok is making AI companions, including a goth anime girl - are they romantic interests or just skins? -Hamleys names Lego, Barbie and Rubik's Cube the top three toys of all time